Patent · US Active

2-aminopyridine compounds

US9834541B2 · kind B2 · utility

1Cited by

2References

7Claims

0Family size

Assignees

Cancer Research Technology Limited · GB
Merck Patent GmbH · DE

Inventors

Kai Schiemann · Darmstadt, DE
Frank Stieber · Heidelberg, DE
Julian Blagg · London, GB
Aurelie MALLINGER · Affléville, FR
Dennis Christian Johannes Waalboer · Weesp, NL
Christian RINK · Bonn, DE
Simon Ross Crumpler · Hertford, GB

Key dates

Filing date	Oct 2, 2013
Grant date	Dec 5, 2017
Priority date	—
Expiry date	Apr 12, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.